CLINOLIPID 20%
Details
- Status
- Prescription
- First Approved
- 2013-10-03
- Routes
- INTRAVENOUS
- Dosage Forms
- EMULSION
CLINOLIPID 20% Approval History
What CLINOLIPID 20% Treats
1 indicationsCLINOLIPID 20% is approved for 1 conditions since its original approval in 2013. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Eczema
Drugs Similar to CLINOLIPID 20%
FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
CLINOLIPID 20% FDA Label Details
ProIndications & Usage
FDA Label (PDF)Use: Temporarily protects and helps relieve minor sk¡n iritationand itching due to rashes and eczema
CLINOLIPID 20% Patents & Exclusivity
Exclusivity
Want competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.